Unlocking Peptides’ Therapeutic Potential through Proper Management of Bioanalysis
The Tufts Center for the Study of Drug Development reports that since 2000 the number of therapeutic peptides in clinical trials has nearly doubled due largely to advances in synthesis, delivery, and formulation techniques. The study notes that 48 therapeutic peptides are now on the market worldwide.